Thrombosis causes: Difference between revisions
Ochuko Ajari (talk | contribs) No edit summary |
m Bot: Automated text replacement (-{{columns-list|3| +{{columns-list|) |
||
(8 intermediate revisions by one other user not shown) | |||
Line 21: | Line 21: | ||
{|style="width:80%; height:100px" border="1" | {|style="width:80%; height:100px" border="1" | ||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | ||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | | |style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Antithrombin III deficiency]], [[aortic dissection]], [[arteritis]], [[atheroma]], [[atherosclerosis]], [[atrial fibrillation]], [[atrioventricular septal defect]], [[cholesterol embolization]], [[congestive heart failure]], [[coronary artery thrombus|coronary artery thrombosis]], [[deep vein thrombosis]], [[defibrination syndrome]], [[disseminated intravascular coagulation]], [[Eisenmenger syndrome]], [[lipoprotein(a)|elevated lipoprotein a]], [[hypercholesterolemia]], [[hyperlipidemia]], [[hypertension]], [[hypertriglyceridemia]], [[Kawasaki disease]], [[left ventricular failure]], [[mesenteric vein thrombosis|mesenteric venous thrombosis]], [[obesity]], [[Paget-Schroetter disease]], [[venous thrombosis|pelvic vein thrombosis]], [[peripheral vascular disease]], [[plasminogen|plasminogen deficiency type I]], [[plasminogen|plasminogen deficiency type II]], [[postphlebitic syndrome]], [[central venous catheter|presence of a central venous catheter]], [[stent]], [[stroke]], [[subclavian vein thrombosis]], [[thrombophlebitis|superficial thrombophlebitis]], [[superior vena cava syndrome]], [[vasculitis]] | ||
|- | |- | ||
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | |bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | ||
Line 32: | Line 32: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Behcet's disease]], [[Klippel Trenaunay syndrome]], [[vasculitis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[Asparaginase Erwinia chrysanthemi]], [[ | |bgcolor="Beige"|[[Aflibercept]], [[Asparaginase Erwinia chrysanthemi]], [[asparaginase]], [[chemotherapy]], [[coagulation factor IX]], [[coagulation factor XIII A-subunit]], [[conestat alfa]], [[desmopressin]], [[elspar]], [[eltrombopag]], [[estramustine]], [[estrogen replacement therapy]], [[ethynodiol diacetate and ethinyl estradiol]], [[femara]], [[glucocorticoids]], [[hormone replacement therapy]], [[iodixanol]], [[lenalidomide]], [[letrozole]], [[L-asparaginase|leunase]], [[meclofenamate]], [[oral contraceptives]], [[pegaspargase]], [[rapamune]], [[romiplostim]],[[sirolimus]], [[tamoxifen]], [[thalidomide]], [[tromethamine]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Ear Nose Throat''' | | '''Ear Nose Throat''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"|[[Mastoiditis]], [[superior vena cava syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"|[[Diabetes mellitus]], [[obesity]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 52: | Line 52: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Budd-Chiari syndrome]], [[chronic pancreatitis]], [[hemorrhoids]], [[hepatic vein thrombosis]], [[inflammatory bowel disease]], [[liver cirrhosis]], [[liver disease]], [[mucormycosis]], [[obesity]], [[pancreatic cancer]], [[zygomycosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[familial dysfibrinogenemia|Ales dysfibrinogenemia]], [[fibronectin|elevated plasma fibronectin levels]], [[factor V Leiden mutation]], [[Marchiafava-Micheli disease]], [[paroxysmal nocturnal hemoglobinuria]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[familial dysfibrinogenemia|Ales dysfibrinogenemia]], [[antiphospholipid syndrome]], [[antithrombin III deficiency]], [[cavernous sinus thrombosis]], [[heparin cofactor II|decreased heparin cofactor II]], [[thrombomodulin|decreased thrombomodulin]], [[tissue factor pathway inhibitor|decreased tissue factor pathway inhibitor (TFPI)]], [[tissue plasminogen activator|decreased tissue plasminogen activator deficiency]], [[deep vein thrombosis]], [[defibrination syndrome]], [[disseminated intravascular coagulation]], [[familial dysfibrinogenemia|dysfibrinogenemia]], [[fibrinogen|elevated fibrinogen]], [[fibronectin|elevated plasma fibronectin levels]], [[thrombin-activatable fibrinolysis inhibitor|elevated thrombin-activatable fibrinolysis inhibitor (TAFI)]], [[essential thrombocythemia]], [[factor XII|factor XII deficiency]], [[heparin-induced thrombocytopenia]], [[hypercoagulability|hypercoagulability syndrome]], [[hyperviscosity syndrome]], [[factor IX|increased factor IX]], [[factor VII|increased factor VII]], [[factor VIII|increased factor VIII]], [[factor XI|increased factor XI]], [[plasminogen activator inhibitor-1|increased plasminogen activator inhibitor-1 (PAI-1)]], [[Klippel Trenaunay syndrome]], [[hyperviscosity syndrome|leukostasis syndrome]], [[Marchiafava-Micheli disease]], [[multiple myeloma]], [[myeloproliferative disorders]], [[Osler-Vaquez disease]], [[Paget-Schroetter disease]], [[paroxysmal nocturnal hemoglobinuria]], [[venous thrombosis|pelvic vein thrombosis]], [[plasminogen|plasminogen deficiency type I]], [[plasminogen|plasminogen deficiency type II]], [[polycythemia vera]], [[polycythemia]], [[postphlebitic syndrome]], [[protein C deficiency]], [[protein S deficiency]], [[prothrombin gene mutation G20210A|prothrombin gene mutation]], [[sickle cell disease]], [[sticky platelet syndrome]], [[superior vena cava syndrome]], [[thrombophilia]], [[thrombotic microangiopathy]], [[Von Willebrand factor]], [[Waldenstrom macroglobulinemia]], [[familial dysfibrinogenemia|Wiesbaden dysfibrinogenemia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 68: | Line 68: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Mastoiditis]], [[meningococcal meningitis]], [[mucormycosis]], [[nipah virus encephalitis]], [[sepsis]], [[zygomycosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal/Orthopedic''' | | '''Musculoskeletal/Orthopedic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Arthroscopy]], [[fracture]], [[hip replacement surgery|hip surgery]], [[immobility]], [[knee pain/swelling surgery|knee surgery]], [[Maffucci syndrome]], [[orthopedic surgery]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Antiphospholipid syndrome]], [[cavernous sinus thrombosis]], [[cerebral venous sinus thrombosis]], [[idiopathic intracranial hypertension]], [[meningococcal meningitis]], [[nipah virus encephalitis]], [[stroke]], [[thoracic inlet|thoracic inlet syndrome]], [[thoracic outlet syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[lipoprotein(a)|Elevated lipoprotein a]], [[glycosylphosphatidylinositol|glycosylphosphatidylinositol deficiency]], [[hyperhomocysteinemia|homocystinemia]], [[hyperhomocysteinemia]], [[hyperlipidemia]], [[hypertriglyceridemia]], [[obesity]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Abruptio placentae]], [[antiphospholipid syndrome]], [[eclampsia]], [[leiomyoma]], [[pre-eclampsia]], [[pregnancy]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Oncologic''' | | '''Oncologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cancer]], [[leukemia]], [[Maffucci syndrome]], [[malignancy]], [[multiple myeloma]], [[myeloproliferative disorders]], [[Osler-Vaquez disease]], [[pancreatic cancer]], [[paraneoplastic syndrome]], [[polycythemia vera]], [[superior vena cava syndrome]], [[Waldenstrom macroglobulinemia]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Ophthalmologic''' | | '''Ophthalmologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[central retinal artery|Retinal artery thrombosis]], [[central retinal vein occlusion|retinal vein thrombosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 108: | Line 108: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Renal/Electrolyte''' | | '''Renal/Electrolyte''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Acute kidney injury]], [[chronic renal disease]], [[nephrotic syndrome]], [[renal vein thrombosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Antiphospholipid syndrome]], [[Behcet's disease]], [[interleukin 8|elevated interleukin 8]], [[Klippel Trenaunay syndrome]], [[polyarteritis nodosa]], [[vasculitis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 120: | Line 120: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Trauma''' | | '''Trauma''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"|[[Trauma]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Urologic''' | | '''Urologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"|[[Fournier gangrene]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[General surgery]], [[high altitude]], [[radiation]], [[smoking]], [[varicose veins]] | ||
|- | |- | ||
|} | |} | ||
===Causes in Alphabetical Order=== | ===Causes in Alphabetical Order=== | ||
{{columns-list | {{columns-list| | ||
*[[Abruptio placentae]] | *[[Abruptio placentae]] | ||
*[[Acute kidney injury]] | *[[Acute kidney injury]] | ||
Line 162: | Line 162: | ||
*[[Conestat alfa]] | *[[Conestat alfa]] | ||
*[[Congestive heart failure]] | *[[Congestive heart failure]] | ||
*[[Coronary artery thrombosis]] | *[[coronary artery thrombus|Coronary artery thrombosis]] | ||
*[[Decreased heparin cofactor II]] | *[[heparin cofactor II|Decreased heparin cofactor II]] | ||
*[[Decreased thrombomodulin]] | *[[thrombomodulin|Decreased thrombomodulin]] | ||
*[[Decreased tissue factor pathway inhibitor (TFPI)]] | *[[tissue factor pathway inhibitor|Decreased tissue factor pathway inhibitor (TFPI)]] | ||
*[[Decreased tissue plasminogen activator deficiency]] | *[[tissue plasminogen activator|Decreased tissue plasminogen activator deficiency]] | ||
*[[Deep vein thrombosis]] | *[[Deep vein thrombosis]] | ||
*[[Defibrination syndrome]] | *[[Defibrination syndrome]] | ||
Line 172: | Line 172: | ||
*[[Diabetes mellitus]] | *[[Diabetes mellitus]] | ||
*[[Disseminated intravascular coagulation]] | *[[Disseminated intravascular coagulation]] | ||
*[[Dysfibrinogenemia]] | *[[familial dysfibrinogenemia|Dysfibrinogenemia]] | ||
*[[Eclampsia]] | *[[Eclampsia]] | ||
*[[Eisenmenger syndrome]] | *[[Eisenmenger syndrome]] | ||
*[[Elevated fibrinogen]] | *[[fibrinogen|Elevated fibrinogen]] | ||
*[[Elevated interleukin 8]] | *[[interleukin 8|Elevated interleukin 8]] | ||
*[[Elevated lipoprotein A]] | *[[lipoprotein(a)|Elevated lipoprotein A]] | ||
*[[Elevated plasma fibronectin levels]] | *[[fibronectin|Elevated plasma fibronectin levels]] | ||
*[[Elevated thrombin- | *[[thrombin-activatable fibrinolysis inhibitor|Elevated thrombin-activatable fibrinolysis inhibitor (TAFI)]] | ||
*[[Elspar]] | *[[Elspar]] | ||
*[[Eltrombopag]] | *[[Eltrombopag]] | ||
Line 187: | Line 187: | ||
*[[Ethynodiol diacetate and ethinyl estradiol]] | *[[Ethynodiol diacetate and ethinyl estradiol]] | ||
*[[Factor V Leiden mutation]] | *[[Factor V Leiden mutation]] | ||
*[[Factor XII deficiency]] | *[[factor XII|Factor XII deficiency]] | ||
*[[Femara]] | *[[Femara]] | ||
*[[Fournier gangrene]] | *[[Fournier gangrene]] | ||
Line 193: | Line 193: | ||
*[[General surgery]] | *[[General surgery]] | ||
*[[Glucocorticoids]] | *[[Glucocorticoids]] | ||
*[[Glycosylphosphatidylinositol deficiency]] | *[[glycosylphosphatidylinositol|Glycosylphosphatidylinositol deficiency]] | ||
*[[Hemorrhoids]] | *[[Hemorrhoids]] | ||
*[[Heparin-induced thrombocytopenia]] | *[[Heparin-induced thrombocytopenia]] | ||
Line 199: | Line 199: | ||
*[[High altitude ]] | *[[High altitude ]] | ||
*[[High altitude]] <ref name="pmid17896862">{{cite journal| author=Kuipers S, Cannegieter SC, Middeldorp S, Robyn L, Büller HR, Rosendaal FR| title=The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations. | journal=PLoS Med | year= 2007 | volume= 4 | issue= 9 | pages= e290 | pmid=17896862 | doi=10.1371/journal.pmed.0040290 | pmc=PMC1989755 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17896862 }} </ref> | *[[High altitude]] <ref name="pmid17896862">{{cite journal| author=Kuipers S, Cannegieter SC, Middeldorp S, Robyn L, Büller HR, Rosendaal FR| title=The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations. | journal=PLoS Med | year= 2007 | volume= 4 | issue= 9 | pages= e290 | pmid=17896862 | doi=10.1371/journal.pmed.0040290 | pmc=PMC1989755 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17896862 }} </ref> | ||
*[[Hip surgery]] | *[[hip replacement surgery|Hip surgery]] | ||
*[[Homocystinemia]] | *[[hyperhomocysteinemia|Homocystinemia]] | ||
*[[Hormone replacement therapy]] | *[[Hormone replacement therapy]] | ||
*[[Hypercholesterolemia]] | *[[Hypercholesterolemia]] | ||
*[[Hypercoagulability syndrome]] | *[[hypercoagulability|Hypercoagulability syndrome]] | ||
*[[Hyperhomocysteinemia]] | *[[Hyperhomocysteinemia]] | ||
*[[Hyperlipidemia]] | *[[Hyperlipidemia]] | ||
Line 211: | Line 211: | ||
*[[Idiopathic intracranial hypertension]] | *[[Idiopathic intracranial hypertension]] | ||
*[[Immobility]] | *[[Immobility]] | ||
*[[Increased factor IX]] | *[[factor IX|Increased factor IX]] | ||
*[[Increased factor VII]] | *[[factor VII|Increased factor VII]] | ||
*[[Increased factor VIII]] | *[[factor VIII|Increased factor VIII]] | ||
*[[Increased factor XI]] | *[[factor XI|Increased factor XI]] | ||
*[[Increased plasminogen activator inhibitor-1 (PAI-1)]] | *[[plasminogen activator inhibitor-1|Increased plasminogen activator inhibitor-1 (PAI-1)]] | ||
*[[Inflammatory bowel disease]] | *[[Inflammatory bowel disease]] | ||
*[[Iodixanol]] | *[[Iodixanol]] | ||
*[[Kawasaki disease]] | *[[Kawasaki disease]] | ||
*[[Klippel Trenaunay syndrome]] | *[[Klippel Trenaunay syndrome]] | ||
*[[Knee surgery]] | *[[knee pain/swelling surgery|Knee surgery]] | ||
*[[Left ventricular failure]] | *[[Left ventricular failure]] | ||
*[[Leiomyoma]] | *[[Leiomyoma]] | ||
Line 226: | Line 226: | ||
*[[Letrozole]] | *[[Letrozole]] | ||
*[[Leukemia]] | *[[Leukemia]] | ||
*[[Leukostasis syndrome]] | *[[hyperviscosity syndrome|Leukostasis syndrome]] | ||
*[[Leunase]] | *[[L-asparaginase|Leunase]] | ||
*[[Liver cirrhosis]] | *[[Liver cirrhosis]] | ||
*[[Liver disease]] | *[[Liver disease]] | ||
Line 236: | Line 236: | ||
*[[Meclofenamate]] | *[[Meclofenamate]] | ||
*[[Meningococcal meningitis]] | *[[Meningococcal meningitis]] | ||
*[[Mesenteric venous thrombosis]] | *[[mesenteric vein thrombosis|Mesenteric venous thrombosis]] | ||
*[[Mucormycosis]] | *[[Mucormycosis]] | ||
*[[Multiple myeloma]] | *[[Multiple myeloma]] | ||
Line 246: | Line 246: | ||
*[[Orthopedic surgery]] | *[[Orthopedic surgery]] | ||
*[[Osler-Vaquez disease]] | *[[Osler-Vaquez disease]] | ||
*[[Paget-Schroetter | *[[Paget-Schroetter disease]] | ||
*[[Pancreatic cancer]] | *[[Pancreatic cancer]] | ||
*[[Paraneoplastic syndrome]] | *[[Paraneoplastic syndrome]] | ||
*[[Paroxysmal nocturnal hemoglobinuria]] | *[[Paroxysmal nocturnal hemoglobinuria]] | ||
*[[Pegaspargase]] | *[[Pegaspargase]] | ||
*[[Pelvic vein thrombosis]] | *[[venous thrombosis|Pelvic vein thrombosis]] | ||
*[[Peripheral vascular disease]] | *[[Peripheral vascular disease]] | ||
*[[Plasminogen deficiency type I]] | *[[plasminogen|Plasminogen deficiency type I]] | ||
*[[Plasminogen deficiency type II]] | *[[plasminogen|Plasminogen deficiency type II]] | ||
*[[Polyarteritis nodosa]] | *[[Polyarteritis nodosa]] | ||
*[[Polycythemia]] | *[[Polycythemia]] | ||
Line 264: | Line 264: | ||
*[[Protein C deficiency]] | *[[Protein C deficiency]] | ||
*[[Protein S deficiency]] | *[[Protein S deficiency]] | ||
*[[Prothrombin gene mutation]] | *[[prothrombin gene mutation G20210A|Prothrombin gene mutation]] | ||
*[[Radiation]] | *[[Radiation]] | ||
*[[Rapamune]] | *[[Rapamune]] | ||
*[[Renal vein thrombosis]] | *[[Renal vein thrombosis]] | ||
*[[Retinal artery thrombosis]] | *[[central retinal artery|Retinal artery thrombosis]] | ||
*[[Retinal vein thrombosis]] | *[[central retinal vein occlusion|Retinal vein thrombosis]] | ||
*[[Romiplostim]] | *[[Romiplostim]] | ||
*[[Sepsis]] | *[[Sepsis]] | ||
Line 279: | Line 279: | ||
*[[Stroke]] | *[[Stroke]] | ||
*[[Subclavian vein thrombosis]] | *[[Subclavian vein thrombosis]] | ||
*[[Superficial thrombophlebitis]] | *[[thrombophlebitis|Superficial thrombophlebitis]] | ||
*[[Superior vena cava syndrome]] | *[[Superior vena cava syndrome]] | ||
*[[Tamoxifen]] | *[[Tamoxifen]] | ||
*[[Thalidomide]] | *[[Thalidomide]] | ||
*[[Thoracic inlet syndrome]] | *[[thoracic inlet|Thoracic inlet syndrome]] | ||
*[[Thoracic outlet syndrome]] | *[[Thoracic outlet syndrome]] | ||
*[[Thrombophilia]] | *[[Thrombophilia]] |
Latest revision as of 23:04, 10 January 2020
Thrombosis Microchapters |
Site of Thrombosis |
---|
Differentiating Thrombosis from other Diseases |
Diagnosis |
Treatment |
Thrombosis causes On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Overview
Thrombosis is caused by abnormalities in one or more of the following (Virchow's triad): the composition of the blood (hypercoagulability or thrombophilia), quality of the vessel wall (endothelial cell injury), and/or nature of the blood flow (stasis, turbulence).
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Causes by Organ System
Causes in Alphabetical Order
- Abruptio placentae
- Acute kidney injury
- Aflibercept
- Ales dysfibrinogenemia
- Antiphospholipid syndrome
- Antithrombin III deficiency
- Aortic dissection
- Arteritis
- Arthroscopy
- Asparaginase
- Asparaginase Erwinia chrysanthemi
- Atheroma
- Atherosclerosis
- Atrial fibrillation
- Atrioventricular septal defect
- Behcet's disease
- Budd-Chiari syndrome
- Cancer
- Cavernous sinus thrombosis
- Cerebral venous sinus thrombosis
- Chemotherapy
- Cholesterol embolization
- Chronic pancreatitis
- Chronic renal disease
- Coagulation factor IX
- Coagulation factor XIII A-subunit
- Conestat alfa
- Congestive heart failure
- Coronary artery thrombosis
- Decreased heparin cofactor II
- Decreased thrombomodulin
- Decreased tissue factor pathway inhibitor (TFPI)
- Decreased tissue plasminogen activator deficiency
- Deep vein thrombosis
- Defibrination syndrome
- Desmopressin
- Diabetes mellitus
- Disseminated intravascular coagulation
- Dysfibrinogenemia
- Eclampsia
- Eisenmenger syndrome
- Elevated fibrinogen
- Elevated interleukin 8
- Elevated lipoprotein A
- Elevated plasma fibronectin levels
- Elevated thrombin-activatable fibrinolysis inhibitor (TAFI)
- Elspar
- Eltrombopag
- Essential thrombocythemia
- Estramustine
- Estrogen replacement therapy
- Ethynodiol diacetate and ethinyl estradiol
- Factor V Leiden mutation
- Factor XII deficiency
- Femara
- Fournier gangrene
- Fracture
- General surgery
- Glucocorticoids
- Glycosylphosphatidylinositol deficiency
- Hemorrhoids
- Heparin-induced thrombocytopenia
- Hepatic vein thrombosis
- High altitude
- High altitude [1]
- Hip surgery
- Homocystinemia
- Hormone replacement therapy
- Hypercholesterolemia
- Hypercoagulability syndrome
- Hyperhomocysteinemia
- Hyperlipidemia
- Hypertension
- Hypertriglyceridemia
- Hyperviscosity syndrome
- Idiopathic intracranial hypertension
- Immobility
- Increased factor IX
- Increased factor VII
- Increased factor VIII
- Increased factor XI
- Increased plasminogen activator inhibitor-1 (PAI-1)
- Inflammatory bowel disease
- Iodixanol
- Kawasaki disease
- Klippel Trenaunay syndrome
- Knee surgery
- Left ventricular failure
- Leiomyoma
- Lenalidomide
- Letrozole
- Leukemia
- Leukostasis syndrome
- Leunase
- Liver cirrhosis
- Liver disease
- Maffucci syndrome
- Malignancy
- Marchiafava-Micheli disease
- Mastoiditis
- Meclofenamate
- Meningococcal meningitis
- Mesenteric venous thrombosis
- Mucormycosis
- Multiple myeloma
- Myeloproliferative disorders
- Nephrotic syndrome
- Nipah virus encephalitis
- Obesity
- Oral contraceptives
- Orthopedic surgery
- Osler-Vaquez disease
- Paget-Schroetter disease
- Pancreatic cancer
- Paraneoplastic syndrome
- Paroxysmal nocturnal hemoglobinuria
- Pegaspargase
- Pelvic vein thrombosis
- Peripheral vascular disease
- Plasminogen deficiency type I
- Plasminogen deficiency type II
- Polyarteritis nodosa
- Polycythemia
- Polycythemia vera
- Postphlebitic syndrome
- Pre-eclampsia
- Pregnancy
- Presence of a central venous catheter
- Protein C deficiency
- Protein S deficiency
- Prothrombin gene mutation
- Radiation
- Rapamune
- Renal vein thrombosis
- Retinal artery thrombosis
- Retinal vein thrombosis
- Romiplostim
- Sepsis
- Sickle cell disease
- Sirolimus
- Smoking
- Stent
- Sticky platelet syndrome [2]
- Stroke
- Subclavian vein thrombosis
- Superficial thrombophlebitis
- Superior vena cava syndrome
- Tamoxifen
- Thalidomide
- Thoracic inlet syndrome
- Thoracic outlet syndrome
- Thrombophilia
- Thrombotic microangiopathy
- Trauma
- Tromethamine
- Varicose veins
- Vasculitis
- Von Willebrand factor
- Waldenstrom macroglobulinemia
- Wiesbaden dysfibrinogenemia
- Zygomycosis
References
- ↑ Kuipers S, Cannegieter SC, Middeldorp S, Robyn L, Büller HR, Rosendaal FR (2007). "The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations". PLoS Med. 4 (9): e290. doi:10.1371/journal.pmed.0040290. PMC 1989755. PMID 17896862.
- ↑ Mammen EF (1999). "Sticky platelet syndrome". Semin Thromb Hemost. 25 (4): 361–5. doi:10.1055/s-2007-994939. PMID 10548069.
cs:Trombóza
de:Thrombose
eo:Trombozo
it:Trombosi
he:תרומבוס
ms:Trombotik
nl:Trombose
fi:Verihiutale